-+ 0.00%
-+ 0.00%
-+ 0.00%

Kazia Therapeutics Announces Promising Early Results in Phase 1b Trial for Triple-Negative Breast Cancer with Paxalisib Combination Therapy

Reuters·07/09/2025 12:00:56

Please log in to view news